AptarGroup

What AptarGroup does

AptarGroup, Inc. (NYSE: ATR), founded in 1946 and headquartered in Crystal Lake, Illinois, is a global manufacturer of drug delivery, dispensing, and active packaging components organized into three reporting segments: Pharma (drug delivery devices, nasal spray systems, injectable components, inhalation devices, and digital health), Beauty (airless packaging, fragrance pumps, droppers, color cosmetic packaging, and personal-care solutions), and Closures (elastomeric flow control valves, disc-top and flip-top closures, and e-commerce-ready caps). The company serves enterprise customers across pharmaceutical and biotech firms, prestige and mass beauty brands, and consumer packaged-goods manufacturers in food, beverage, home, and personal care markets, with manufacturing and commercial operations in more than 20 countries and approximately 14,000 employees.

Aptar's product portfolio is built around proprietary elastomeric and dispensing technologies with patent-protected platforms including the Gaïa reloadable airless system (73% material impact reduction per refill), SimpliSqueeze silicone flow control valves (30+ billion units sold over 25+ years), SureSnap pre-assembled valve-and-retaining-ring systems, the NeoDropper Autoload dosing mechanism, and 3-Phase Activ-Polymer moisture protection used in unidose nasal drug delivery. The Pharma segment has been the principal growth engine, posting a 24% surge in injectables sales in Q4 2025 driven by GLP-1 demand, while the Digital Health platform — strengthened through the 2021 Voluntis acquisition and the 2026 partnership with Enable Injections — extends Aptar into software-connected therapy support.

Aptar generates revenue through B2B direct enterprise sales on quote-based, multi-year contracts to global and regional pharmaceutical, beauty, and consumer-product manufacturers. FY2025 reported sales reached $3.78 billion, with Q1 2026 sales of $982.9 million (+10.8% year-over-year), supported by GLP-1-related injectables growth, sustained demand for refillable and e-commerce-ready packaging, and bolt-on acquisitions including Sommaplast (Brazil, 2025), Mod3 Pharma (clinical trial materials, 2025), Weihai Hengyu (China, 2021), and Voluntis (2021). The company has compounded shareholder returns through 33 consecutive years of dividend increases and a $600 million share repurchase authorization announced in 2026, with a planned CEO succession from Stephan B. Tanda to Gael Touya effective September 1, 2026.

Name

AptarGroup

Legal name

APTARGROUP, INC.

Website

https://aptar.com

Company type

Public

Founded year

1946

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

AptarGroup (NYSE: ATR) is a global manufacturer of drug delivery devices, beauty dispensing systems, and packaging closures serving pharmaceutical, biotech, beauty, and consumer product companies across 20+ countries with proprietary elastomeric and dispensing technologies.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Consumer Packaging Components

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)

akta.pro secondary industries

Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Drug delivery systems
• Dispensing packaging components
• Pharmaceutical elastomeric components
• Beauty airless packaging
• Dispensing closures

Headquarters

HQ city

Crystal Lake

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical segment: Drug delivery solutions including nasal delivery systems, injectables, respiratory delivery, and digital health products serving pharmaceutical and biotech clients. Q4 2025 showed Pharma injectables surging 24% on GLP-1 demand.
2. Beauty segment: Beauty packaging and dispensing solutions for fragrance, color cosmetics, skincare, and personal care including airless systems, pumps, droppers, and closures. Products sold to prestige and mass beauty brands globally.
3. Closures segment: Dispensing closures and flow control solutions for food, beverage, home care, and personal care markets. Includes elastomeric flow control valves, disc top caps, and e-commerce capable closures.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

AptarGroup manufactures and sells proprietary drug delivery, dosing, and protection systems for pharmaceutical and biotech companies, and dispensing, airless, and closure packaging components for beauty, personal care, food, beverage, and home care brands. The portfolio spans nasal and respiratory delivery devices, elastomeric syringe and vial components, prefilled injectable components, digital health platforms, silicone flow control valves, airless pumps, droppers, fragrance pumps, and a range of dispensing closures.

Product overview

AptarGroup is a global leader in drug delivery, dosing, protection, and consumer product dispensing technologies operating across three segments: Pharma, Beauty, and Closures. The company offers a comprehensive portfolio of proprietary technologies including the NeoDropper Autoload auto-loading dropper and Gaïa reloadable airless platform for skincare applications; SimpliSqueeze, SureSnap, and SimpliCycle elastomeric flow control valve technologies; Future Disc Top and E-Disc Top e-commerce-ready closures; and Cleo/Airy inverted lidless closures for beauty and personal care. In pharmaceutical markets, Aptar provides nasal delivery systems (Unidose Powder, Intranasal), connected inhalers, prefilled syringe components, and Digital Health platforms integrating with wearable infusion devices. The portfolio spans aerosol, airless, closures, cosmetic pumps, dispensing pumps, droppers, fragrance pumps, inhalers, multidose systems, and sampling solutions, serving pharmaceutical, beauty, food, beverage, and home care end markets across 20 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Aptar Pharma: Drug delivery, dosing and protection technologies for pharmaceutical applications
• Aptar Beauty
• Aptar Closures
• Aptar Digital Health
• Aptar Europe Holding SAS

Products and services

• NeoDropper Autoload Next-generation auto-loading dosing dropper for dermocosmetic and prestige skincare markets featuring a twist-and-push mechanism that automatically reloads the applicator with a precise dose, improves hygiene, and minimizes product waste; demonstrates four times lower microbial contamination versus traditional droppers in independent laboratory testing.
• Gaïa Reloadable Airless Highly customizable reloadable airless platform with a patented push-pull reload mechanism featuring a distinctive click closure and double tamper seal system; protects sensitive formulas from oxidation and contamination, offers premium aesthetics and high recyclability in PP and PE streams, and reduces material impact by 73% per refill.
• Future Disc Top Closure Fully recyclable disc top closure made from 100% polyethylene, e-commerce capable with incorporated locking/unlocking ring, and suitable for a range of viscosities; certified recyclable by RecyClass and Institut cyclos-HTP, with ISTA-6 compliance for e-commerce transit reliability.
• E-Disc Top Closure E-commerce capable disc top closure that is ISTA-6 qualified, designed to withstand harsh shipping conditions of online shopping while providing a consumer-friendly opening and dispensing experience; eliminates the need for liners, shrink bands, and excess packaging, and is fully recyclable with PCR options available.
• Cleo and Airy Inverted Lidless Closures Inverted lidless dispensing closures for beauty and personal care markets featuring SimpliSqueeze flow control valve technology; enables inverted ready-to-dispense packaging, eliminates the need for separate lids, reduces mess, drips and product waste, and enables single-handed operation.
• SimpliSqueeze Silicone Flow Control Valve

Quantifiable outcome

• 73% material impact reduction per reload with Gaïa technology vs. previous packaging
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• DermalogicacoreStrategic or Co-development Partner · 20 July 2026Commercial launch of NeoDropper Autoload technology on Dermalogica's FutureCode Booster skincare product, featuring twist-and-push dispensing with automatic loading system. Dermalogica previously became first prestige skincare brand in 2022 to use Aptar's recyclable Future dispensing pump.
• ClarinscoreStrategic or Co-development Partner · 6 May 2026Long-standing partnership developing patented Gaïa reloadable airless packaging for Clarins Total Eye Lift Eye Cream, achieving 73% material impact reduction per reload. Partnership also includes Double Serum Hybrid Foundation with custom dual-chamber packaging. Collaboration recognized with DIELINE Award 2026 and Formes de Luxe Award 2025.
• Cheer Pack North AmericacoreTechnology or Integration · 13 April 2026Multi-year collaboration integrating Aptar's SureSnap flow control valve and retaining ring technology into Cheer Pack's SqueezeNSip spouted pouch, enabling leak-free dispensing for beverages and low-viscosity items using up to 60% less material than rigid bottles. Partnership spans over a decade of collaborative pouch, spout, and valve dispensing solutions.
• Enable InjectionscoreTechnology or Integration · 11 April 2026Aptar Digital Health named preferred digital health partner for Enable's enFuse wearable infusion system, pairing the device with Aptar's software for treatment data recording, patient onboarding, and injection guidance. Extends Aptar beyond physical drug delivery into integrated digital platforms for clinical trials and commercial therapies.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• West Pharmaceutical Services: Primary direct competitor in elastomeric components, seals, and stoppers for injectable drug delivery. Both serve pharma and biotech customers with primary packaging for prefilled syringes and vials, making product portfolios and customer bases highly aligned.
• Gerresheimer AG: Global pharmaceutical packaging manufacturer producing glass vials, ampoules, syringes, and plastic containers for pharma and cosmetics. Direct overlap with Aptar's pharma packaging and beauty packaging portfolios.
• Stevanato Group: Italian pharmaceutical packaging and drug delivery systems manufacturer specializing in glass vials, syringes, and integrated devices. Comparable to Aptar Pharma in serving injectable and inhalation drug delivery applications.
• SCHOTT Pharma: Subsidiary of SCHOTT AG producing pharmaceutical glass and packaging, including vials, syringes, and ampoules. Direct competitor in primary pharmaceutical packaging serving injectable drug manufacturers.
• Silgan Holdings: Closures and dispensing systems manufacturer through its Dispensing & Specialty Closures segment. Direct competitor in dispensing closures, pumps, and sprayers for personal care, beauty, and food/beverage markets, comparable to Aptar Closures.
• Albea Group: Global beauty packaging manufacturer producing tubes, dispensing systems, and beauty packaging solutions. Direct competitor in Aptar Beauty's fragrance, skincare, and color cosmetics packaging segments, serving similar prestige and mass beauty brand customers.

Broad incumbents

• Amcor: Global packaging incumbent with broad flexible and rigid plastic packaging across pharma, beauty, food, and healthcare. Amcor's pharma packaging business overlaps with Aptar's pharma and closures segments, though Aptar focuses more on dispensing and drug delivery.
• Becton Dickinson: Global medical technology company with pharmaceutical systems business supplying prefilled syringes, injection devices, and drug delivery. Overlaps with Aptar's pharma injectables and digital health platform offerings, but operates at much broader scale across medtech.
• Berry Global: Large diversified packaging manufacturer with significant presence in healthcare, beauty, and consumer product packaging. Comparable to Aptar's closures and beauty segments, though more focused on rigid containers and films.

Emerging players

• Catalent: Pharmaceutical contract development and manufacturing organization with drug delivery and softgel capabilities. Partial overlap with Aptar's pharma services through Nanopharm (formulation development) and integrations with Noble and Voluntis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/aptar
• YouTubeyoutube.com/channel/UCiJBTIPS0hWx9NCfTmbgOVA
• Facebookfacebook.com/Aptar-649067341779216
• LinkedInlinkedin.com/company/aptargroup-inc.
• Instagraminstagram.com/aptargroup

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Subsidiaries6 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A12 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AptarGroup